160 related articles for article (PubMed ID: 9647471)
41. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
O'Loinsigh ED; Boland G; Kelly JP; O'Boyle KM
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):621-38. PubMed ID: 11371001
[TBL] [Abstract][Full Text] [Related]
42. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS
Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680
[TBL] [Abstract][Full Text] [Related]
43. Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats.
Wallinga AE; Grahlmann C; Granneman RA; Koolhaas JM; Buwalda B
Brain Res; 2011 Jun; 1398():13-20. PubMed ID: 21620380
[TBL] [Abstract][Full Text] [Related]
44. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
Nash JF; Arora RC; Schreiber MA; Meltzer HY
Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
[TBL] [Abstract][Full Text] [Related]
45. Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain.
Torres E; Gutierrez-Lopez MD; Borcel E; Peraile I; Mayado A; O'Shea E; Colado MI
J Neurochem; 2010 Apr; 113(1):67-78. PubMed ID: 20067581
[TBL] [Abstract][Full Text] [Related]
46. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
47. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
[TBL] [Abstract][Full Text] [Related]
48. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS
Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472
[TBL] [Abstract][Full Text] [Related]
49. Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY; Dersch C; Rothman R; Cadet JL
Synapse; 1999 Sep; 33(3):207-17. PubMed ID: 10420168
[TBL] [Abstract][Full Text] [Related]
50. Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures.
Green AR; O'Shea E; Saadat KS; Elliott JM; Colado MI
Br J Pharmacol; 2005 Sep; 146(2):306-12. PubMed ID: 15997230
[TBL] [Abstract][Full Text] [Related]
51. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
Freezer A; Salem A; Irvine RJ
Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
[TBL] [Abstract][Full Text] [Related]
52. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.
Izco M; Orio L; O'Shea E; Colado MI
Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928
[TBL] [Abstract][Full Text] [Related]
53. Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.
Vanattou-Saïfoudine N; McNamara R; Harkin A
Br J Pharmacol; 2010 Jun; 160(4):860-77. PubMed ID: 20590585
[TBL] [Abstract][Full Text] [Related]
54. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
55. Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity.
Aguirre N; Barrionuevo M; Ramírez MJ; Del Río J; Lasheras B
Neuroreport; 1999 Nov; 10(17):3675-80. PubMed ID: 10619665
[TBL] [Abstract][Full Text] [Related]
56. Studies on the mechanism of p-chloroamphetamine neurotoxicity.
Sprague JE; Johnson MP; Schmidt CJ; Nichols DE
Biochem Pharmacol; 1996 Oct; 52(8):1271-7. PubMed ID: 8937435
[TBL] [Abstract][Full Text] [Related]
57. Rapid and long-lasting tolerance to clomethiazole-induced hypothermia in the rat.
Visser SA; Pozarek S; Martinsson S; Forsberg T; Ross SB; Gabrielsson J
Eur J Pharmacol; 2005 Apr; 512(2-3):139-51. PubMed ID: 15840398
[TBL] [Abstract][Full Text] [Related]
58. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Goñi-Allo B; Puerta E; Hervias I; Di Palma R; Ramos M; Lasheras B; Aguirre N
Eur J Pharmacol; 2007 May; 562(3):198-207. PubMed ID: 17320075
[TBL] [Abstract][Full Text] [Related]
59. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
60. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain.
Bhide NS; Lipton JW; Cunningham JI; Yamamoto BK; Gudelsky GA
Brain Res; 2009 Aug; 1286():32-41. PubMed ID: 19555677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
